UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain

Journal of clinical immunology, 2021-07, Vol.41 (5), p.914-922

2021

Volltextzugriff (PDF)

Oral bulky lesions related to advanced HIV infection

Postgraduate medical journal, 2020-02, Vol.96 (1132), p.114-114

2020

Volltextzugriff (PDF)

Safety and Tolerability: Current Challenges to Antiretroviral Therapy for the Long-Term Management of HIV Infection

AIDS reviews, 2016-07, Vol.18 (3), p.127-137

2016

Volltextzugriff (PDF)

Gender-based vulnerability in women who inject drugs in a harm reduction setting

PloS one, 2020-03, Vol.15 (3), p.e0230886-e0230886

2020

Volltextzugriff (PDF)

Low Lymphocytes and IFN-Neutralizing Autoantibodies as Biomarkers of COVID-19 Mortality

Journal of clinical immunology, 2022-05, Vol.42 (4), p.738-741

2022

Volltextzugriff (PDF)

Aortic thrombus in patients with severe COVID-19: review of three cases

Journal of thrombosis and thrombolysis, 2021-01, Vol.51 (1), p.237-242

2021

Volltextzugriff (PDF)

Artificial intelligence model for tumoral clinical decision support systems

Computer methods and programs in biomedicine, 2024-08, Vol.253, p.108228-108228, Article 108228

2024

Volltextzugriff (PDF)

Effect of Steam Injection during Carbonation on the Multicyclic Performance of Limestone (CaCO3) under Different Calcium Looping Conditions: A Comparative Study

ACS sustainable chemistry & engineering, 2022-01, Vol.10 (2), p.850-859

2022

Volltextzugriff (PDF)

Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study

AIDS patient care and STDs, 2018-03, Vol.32 (3), p.112-118

2018

Volltextzugriff (PDF)

HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study

The International journal of drug policy, 2021-06, Vol.92, p.103134-103134, Article 103134

2021

Volltextzugriff (PDF)

HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination

PloS one, 2018-10, Vol.13 (10), p.e0204795-e0204795

2018

Volltextzugriff (PDF)

Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

Viruses, 2023-04, Vol.15 (4), p.936

2023

Volltextzugriff (PDF)

Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study

Journal of antimicrobial chemotherapy, 2024-03, Vol.79 (3), p.595-607

2024

Volltextzugriff (PDF)

Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs

AIDS care, 2022-10, Vol.34 (10), p.1297-1304

2022

Volltextzugriff (PDF)

Mephedrone and chemsex: when it stops being a party and becomes a fatal problem

International journal of STD & AIDS, 2019-09, Vol.30 (10), p.1028-1030

2019

Volltextzugriff (PDF)

Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care

Liver international, 2022-02, Vol.42 (2), p.309-319

2022

Volltextzugriff (PDF)

HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

Biomedicine & pharmacotherapy, 2022-01, Vol.145, p.112405-112405, Article 112405

2022

Volltextzugriff (PDF)

High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis

AIDS (London), 2018-06, Vol.32 (9), p.1157-1163

2018

Volltextzugriff (PDF)

High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units

The International journal of drug policy, 2019-10, Vol.72, p.181-188

2019

Volltextzugriff (PDF)

Improvisation in times of pandemic, a reason for reflection

International journal of infectious diseases, 2020-07, Vol.96, p.361-362

2020

Volltextzugriff (PDF)

Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study

PloS one, 2018-06, Vol.13 (6), p.e0198768

2018

Volltextzugriff (PDF)

Geriatric-HIV Medicine: the geriatrician’s role

European geriatric medicine, 2019-04, Vol.10 (2), p.259-265

2019

Volltextzugriff (PDF)

Health care issues affecting transgender people living with HIV: an opportunity for improvement

International journal of STD & AIDS, 2020-08, Vol.31 (9), p.859-865

2020

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(118)
Spanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(63)
Humans
(46)
Infectious Diseases
(33)
Male
(30)
Middle Aged
(27)
Female
(25)
Hiv
(25)
Adult
(24)
Human Immunodeficiency Virus
(20)
Immunology
(20)
Hiv Infections - Drug Therapy
(15)
Infections
(15)
Covid-19
(13)
General & Internal Medicine
(12)
Medicine, General & Internal
(12)
Patients
(12)
Acquired Immune Deficiency Syndrome
(11)
Aids
(11)
Antiretroviral Drugs
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain

Oral bulky lesions related to advanced HIV infection

Safety and Tolerability: Current Challenges to Antiretroviral Therapy for the Long-Term Management of HIV Infection

Gender-based vulnerability in women who inject drugs in a harm reduction setting

Low Lymphocytes and IFN-Neutralizing Autoantibodies as Biomarkers of COVID-19 Mortality

Aortic thrombus in patients with severe COVID-19: review of three cases

Artificial intelligence model for tumoral clinical decision support systems

Effect of Steam Injection during Carbonation on the Multicyclic Performance of Limestone (CaCO3) under Different Calcium Looping Conditions: A Comparative Study

Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study

HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study

HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination

Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study

Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs

Mephedrone and chemsex: when it stops being a party and becomes a fatal problem

Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis

Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic

High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units

Improvisation in times of pandemic, a reason for reflection

Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study

Geriatric-HIV Medicine: the geriatrician’s role

Health care issues affecting transgender people living with HIV: an opportunity for improvement

Suchergebnisse filtern